{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:47:26Z","timestamp":1774705646792,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The antifungal susceptibility testing (AFST) of yeast pathogen alerts clinicians about the potential emergence of resistance. In this study, we compared two commercial microdilution AFST methods: Sensititre YeastOne read visually (YO) and MICRONAUT-AM read visually (MN) or spectrophotometrically (MNV), interpreted with Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing criteria, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Overall, 97 strains from 19 yeast species were measured for nine antifungal drugs including a total of 873 observations. First, the minimal inhibitory concentration (MIC) was compared between YO and MNV, and between MNV and MN, either directly or by assigning them to five susceptibility categories. Those categories were based on the number of MIC dilutions around the breakpoint or epidemiological cut-off reference values (ECOFFs or ECVs). Second, YO and MNV methods were evaluated for their ability to detect the elevation of MICs due to mutation in antifungal resistance genes, thanks to pairs or triplets of isogenic strains isolated from a single patient along a treatment previously analyzed for antifungal resistance gene mutations. Reproducibility measurement was evaluated, thanks to three quality control (QC) strains.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>YO and MNV direct MIC comparisons obtained a global agreement of 67%. Performing susceptibility category comparisons, only 22% and 49% of the MICs could be assigned to categories using breakpoints and ECOFFs\/ECVs, respectively, and 40% could not be assigned due to the lack of criteria in both consortia. The YO and MN susceptibility categories gave accuracies as low as 50%, revealing the difficulty to implement this method of comparison. In contrast, using the antifungal resistance gene sequences as a gold standard, we demonstrated that both methods (YO and MN) were equally able to detect the acquisition of resistance in the <jats:italic>Candida<\/jats:italic> strains, even if MN showed a global lower MIC elevation than YO. Finally, no major differences in reproducibility were observed between the three AFST methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study demonstrates the valuable use of both commercial microdilution AFST methods to detect antifungal resistance due to point mutations in antifungal resistance genes. We highlighted the difficulty to conduct conclusive analyses without antifungal gene sequence data as a gold standard. Indeed, MIC comparisons taking into account the consortia criteria of interpretation remain difficult even after the effort of harmonization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.859439","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:16:55Z","timestamp":1651648615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems"],"prefix":"10.3389","volume":"12","author":[{"given":"Nicolas","family":"Pellaton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Sanglard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Lamoth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alix T.","family":"Coste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1128\/AAC.00512-17","article-title":"Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins Against Candida Species From a Single Center in Austria","volume":"61","author":"Aigner","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00170-20","article-title":"Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida Albicans Using a Validated In Vitro Pharmacokinetic\/Pharmacodynamic Model","volume":"64","author":"Beredaki","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug Resistance and Tolerance in Fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/jof7090760","article-title":"Participation of the ABC Transporter CDR1 in Azole Resistance of Candida Lusitaniae","volume":"7","author":"Borgeat","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02788","article-title":"Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida Auris","volume":"10","author":"Chaabane","year":"2019","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080612","article-title":"Mechanisms of Azole Resistance and Trailing in Candida Tropicalis Bloodstream Isolates","volume":"7","author":"Chen","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7882","DOI":"10.1128\/AAC.02107-15","article-title":"Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B Against Molecularly Identified Mucorales Species","volume":"59","author":"Chowdhary","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dkx480","article-title":"A Multicentre Study of Antifungal Susceptibility Patterns Among 350 Candida Auris Isolates (2009-17) in India: Role of the ERG11 and FKS1 Genes in Azole and Echinocandin Resistance","volume":"73","author":"Chowdhary","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida Albicans Isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s15010-020-01475-8","article-title":"Emerging Echinocandin-Resistant Candida Albicans and Glabrata in Switzerland","volume":"48","author":"Coste","year":"2020","journal-title":"Infection"},{"key":"B11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jgar.2020.06.025","article-title":"Echinocandin Resistance in Candida Parapsilosis Sensu Stricto: Role of Alterations in CHS3, FKS1 and Rho Gene Expression","volume":"22","author":"Davari","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03000","article-title":"Machine Learning Approach for Candida Albicans Fluconazole Resistance Detection Using Matrix-Assisted Laser Desorption\/Ionization Time-Of-Flight Mass Spectrometry","volume":"10","author":"Delavy","year":"2019","journal-title":"Front. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1128\/AAC.00088-08","article-title":"Mutations in the Fks1 Gene in Candida Albicans, C. Tropicalis and C. Krusei Correlate With Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing","volume":"52","author":"Desnos-Ollivier","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1000268","DOI":"10.1371\/journal.ppat.1000268","article-title":"Gain of Function Mutations in CgPDR1 of Candida Glabrata Not Only Mediate Antifungal Resistance But Also Enhance Virulence","volume":"5","author":"Ferrari","year":"2009","journal-title":"PloS Pathog."},{"key":"B15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00328721","article-title":"Isolation of the Candida Albicans Gene for Orotidine-5\u2019-Phosphate Decarboxylase by Complementation of S. Cerevisiae Ura3 and E. Coli pyrF Mutations","volume":"198","author":"Gillum","year":"1984","journal-title":"Mol. Gen. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1128\/AAC.06253-11","article-title":"Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida Glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B","volume":"56","author":"Hull","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02512-19","article-title":"Comparative Genomics for the Elucidation of Multidrug Resistance in Candida Lusitaniae","volume":"10","author":"Kannan","year":"2019","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/jof7010063","article-title":"Rapid Antifungal Susceptibility Testing of Yeasts and Molds by MALDI-TOF MS: A Systematic Review and Meta-Analysis","volume":"7","author":"Knoll","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1214 e1","DOI":"10.1016\/j.cmi.2018.05.012","article-title":"Accuracy of Sensititre YeastOne Echinocandins Epidemiological Cut-Off Values for Identification of FKS Mutant Candida Albicans and Candida Glabrata: A Ten Year National Survey of the Fungal Infection Network of Switzerland (FUNGINOS)","volume":"24","author":"Kritikos","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B20","doi-asserted-by":"publisher","first-page":"i4","DOI":"10.1093\/jac\/dkx444","article-title":"Changes in the Epidemiological Landscape of Invasive Candidiasis","volume":"73","author":"Lamoth","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02663-20","article-title":"Novel ERG11 and TAC1b Mutations Associated With Azole Resistance in Candida Auris","volume":"61","author":"Li","year":"2021","journal-title":"Antimicrob. Agents Chemother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01342-17","article-title":"Mediator Tail Module Is Required for Tac1-Activated CDR1 Expression and Azole Resistance in Candida Albicans","volume":"61","author":"Liu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1439-0507.2004.01013.x","article-title":"Comparative Evaluation of Sensititre YeastOne vs. The NCCLS M27A Protocol and E-Test for Antifungal Susceptibility Testing of Yeasts","volume":"47","author":"Lombardi","year":"2004","journal-title":"Mycoses"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1128\/AAC.01645-09","article-title":"Genetic Dissection of Azole Resistance Mechanisms in Candida Albicans and Their Validation in a Mouse Model of Disseminated Infection","volume":"54","author":"MacCallum","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/AAC.04922-14","article-title":"Implication of Candida Parapsilosis FKS1 and FKS2 Mutations in Reduced Echinocandin Susceptibility","volume":"59","author":"Marti-Carrizosa","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1128\/AAC.01027-16","article-title":"Intra- and Interlaboratory Agreement in Assessing the In Vitro Activity of Micafungin Against Common and Rare Candida Species With the EUCAST, CLSI, and Etest Methods","volume":"60","author":"Meletiadis","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for Amino Acid Substitutions in the Candida Albicans Erg11 Protein of Azole-Susceptible and Azole-Resistant Clinical Isolates: New Substitutions and a Review of the Literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-Type MIC Distributions, Epidemiological Cutoff Values and Species-Specific Clinical Breakpoints for Fluconazole and Candida: Time for Harmonization of CLSI and EUCAST Broth Microdilution Methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist. Update"},{"key":"B29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2014.03.004","article-title":"Comparison of EUCAST and CLSI Broth Microdilution Methods for the Susceptibility Testing of 10 Systemically Active Antifungal Agents When Tested Against Candida","volume":"79","author":"Pfaller","year":"2014","journal-title":"spp. Diagn. Microbiol. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jof7050356","article-title":"Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne Versus MICRONAUT-AM","volume":"7","author":"Philips","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","article-title":"Antifungal Drug Resistance Mechanisms in Fungal Pathogens From the Perspective of Transcriptional Gene Regulation","volume":"9","author":"Sanglard","year":"2009","journal-title":"FEMS Yeast Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","article-title":"History of the Development of Antifungal Azoles: A Review on Structures, SAR, and Mechanism of Action","volume":"104","author":"Shafiei","year":"2020","journal-title":"Bioorg. Chem."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.586540","article-title":"Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51","volume":"7","author":"Shi","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida Glabrata, Candida Parapsilosis and Candida Tropicalis: Biology, Epidemiology, Pathogenicity and Antifungal Resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"713687","DOI":"10.1155\/2012\/713687","article-title":"Antifungal Resistance and New Strategies to Control Fungal Infections","volume":"2012","author":"Vandeputte","year":"2012","journal-title":"Int. J. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/AAC.47.9.2717-2724.2003","article-title":"Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida Lusitaniae","volume":"47","author":"Young","year":"2003","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.859439\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:16:59Z","timestamp":1651648619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.859439\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2022.859439"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.859439","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"article-number":"859439"}}